These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25693997)

  • 41. Pharmacokinetics of single-dose sildenafil administered orally in clinically healthy dogs: Effect of feeding and dose proportionality.
    Akabane R; Sato T; Sakatani A; Miyagawa Y; Tazaki H; Takemura N
    J Vet Pharmacol Ther; 2018 Jun; 41(3):457-462. PubMed ID: 29352474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Drug-drug interaction with telaprevir or boceprevir in liver transplant patients: about four cases].
    Delaborde L; Logerot S; Fonrose X
    Therapie; 2014; 69(6):491-7. PubMed ID: 25320939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.
    Hézode C; Fontaine H; Dorival C; Larrey D; Zoulim F; Canva V; de Ledinghen V; Poynard T; Samuel D; Bourlière M; Zarski JP; Raabe JJ; Alric L; Marcellin P; Riachi G; Bernard PH; Loustaud-Ratti V; Métivier S; Tran A; Serfaty L; Abergel A; Causse X; Di Martino V; Guyader D; Lucidarme D; Grando-Lemaire V; Hillon P; Feray C; Dao T; Cacoub P; Rosa I; Attali P; Petrov-Sanchez V; Barthe Y; Pawlotsky JM; Pol S; Carrat F; Bronowicki JP;
    J Hepatol; 2013 Sep; 59(3):434-41. PubMed ID: 23669289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment.
    Hosny KM; El-Say KM; Ahmed OA
    Drug Deliv; 2016; 23(1):355-61. PubMed ID: 24865296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
    Martin DE; Galbraith H; Schettler J; Ellis C; Doto J
    Clin Ther; 2008 Oct; 30(10):1794-805. PubMed ID: 19014835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Boceprevir and telaprevir-based regimens for the treatment of hepatitis C virus in HIV/HCV coinfected patients.
    Beste LA; Green PK; Ioannou GN
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):123-9. PubMed ID: 25503739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ritonavir boosting dose reduction from 100 to 50 mg does not change the atazanavir steady-state exposure in healthy volunteers.
    Estévez JA; Moltó J; Tuneu L; Cedeño S; Antonijoan RM; Mangues MA; Clotet B; Domingo P; Puntes M; Barbanoj MJ; Valle M
    J Antimicrob Chemother; 2012 Aug; 67(8):2013-9. PubMed ID: 22566588
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: results of an open label, randomized, prospective clinical study.
    Krause P; Fuhr U; Schnitker J; Albrecht U; Stein R; Rubenwolf P
    J Urol; 2013 Nov; 190(5):1791-7. PubMed ID: 23669567
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of gemfibrozil, rifampicin, or probenecid on the pharmacokinetics of the SGLT2 inhibitor empagliflozin in healthy volunteers.
    Macha S; Koenen R; Sennewald R; Schöne K; Hummel N; Riedmaier S; Woerle HJ; Salsali A; Broedl UC
    Clin Ther; 2014 Feb; 36(2):280-90.e1. PubMed ID: 24491572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ketoconazole on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor teneligliptin: an open-label study in healthy white subjects in Germany.
    Nakamaru Y; Hayashi Y; Sekine M; Kinoshita S; Thompson J; Kawaguchi A; Davies M; Jürgen Heuer H; Yamazaki H; Akimoto K
    Clin Ther; 2014 May; 36(5):760-9. PubMed ID: 24726088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the Pharmacokinetic Interaction Between the Voltage- and Use-Dependent Nav1.7 Channel Blocker Vixotrigine and Carbamazepine in Healthy Volunteers.
    Dunbar J; Versavel M; Zhao Y; Tate S; Morisset V; Giblin GMP; Palmer J; Tidemann-Miller B; Naik H
    Clin Pharmacol Drug Dev; 2020 Jan; 9(1):62-73. PubMed ID: 31650711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of single dose sildenafil orally administered in canine models of chronic embolic pulmonary hypertension.
    Akabane R; Sato T; Sakatani A; Ogawa M; Nagakawa M; Miyakawa H; Miyagawa Y; Tazaki H; Takemura N
    J Vet Med Sci; 2020 Apr; 82(4):446-451. PubMed ID: 32101822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of Eruca sativa (Arugula) on pharmacokinetics of Sildenafil in rats.
    Mallah E; Saleh S; Rayyan WA; Dayyih WA; Elhajji FD; Mima M; Awad R; Arafat T
    Neuro Endocrinol Lett; 2017 Aug; 38(4):295-300. PubMed ID: 28871716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Because it's embarrassing?
    Ørstavik RE
    Tidsskr Nor Laegeforen; 2019 Sep; 139(13):. PubMed ID: 31556514
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacokinetics and Tolerability of Intravenous Sildenafil in Two Subjects with Child-Turcotte-Pugh Class C Cirrhosis and Renal Dysfunction.
    Mindikoglu AL; Dowling TC; Schaub DJ; Hutson WR; Potosky DR; Christenson RH; Barth RN; LaMattina JC; Hanish SI; Weir MR; Raufman JP
    Dig Dis Sci; 2015 Nov; 60(11):3491-4. PubMed ID: 26143343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.